Deltex Medical Group (DEMG) Share Price, News & Analysis

Company Overview

Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers oesophageal Doppler Probes that is used to measure a patient's central vascular blood flow and fluid status to measure real time blood velocities within the descending aorta; TrueVue Loops that plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure waveform analysis algorithm used during periods of instability or for periods when the ODM mode is unavailable. The company also provides Deltex Medical Esophageal Doppler Simulator that enables clinicians to practice probe insertion, focusing, and waveform interpretation outside of a patient setting. Its products are used in Covid-19 critical care; sepsis; major abdominal, laparoscopic, and spinal surgeries; cardiac, trauma, and transplant procedures; and post-operative acute kidney injury monitoring. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.

Key Stats

• Today's Range: 0.08 to 0.08
• 50-Day Range: 0.08 to 0.12
• 52-Week Range: 0.07 to 0.20
• Volume: 500,641 shs
• Average Volume: 2.90 million shs
• Market Capitalization: £1.44 million
• P/E Ratio: N/A
• Dividend Yield: 2.19%
• Price Target: N/A
• Consensus Rating: N/A

DEMG Stock Analysis - Frequently Asked Questions

How have DEMG shares performed this year?

Deltex Medical Group's stock was trading at GBX 0.15 at the beginning of 2024. Since then, DEMG shares have decreased by 47.6% and is now trading at GBX 0.08.
View the best growth stocks for 2024 here.

How were Deltex Medical Group's earnings last quarter?

Deltex Medical Group plc (LON:DEMG) released its earnings results on Monday, September, 21st. The company reported ($0.11) earnings per share for the quarter. Deltex Medical Group had a negative net margin of 72.49% and a negative trailing twelve-month return on equity of 57.02%.

How do I buy shares of Deltex Medical Group?

Shares of DEMG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Deltex Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Deltex Medical Group investors own include Indivior (INDV), Nanoco Group (NANO), Tullow Oil (TLW), Ocado Group (OCDO), Bigblu Broadband (BBB), B&M European Value Retail (BME) and BP (BP).

Company Calendar

• Last Earnings: 9/21/2020
• Today: 11/21/2024

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: LON:DEMG
• CUSIP: N/A
• CIK: N/A
• Web: www.deltexmedical.com
• Phone: +44-1243-774837
• Fax: N/A
• Employees: 37
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 15.66
• P/E Growth: N/A
• Net Income: £-1,290,000.00
• Net Margins: -72.49%
• Pretax Margin: N/A
• Return on Equity: -57.02%
• Return on Assets: -7.77%

Debt

• Debt-to-Equity Ratio: 73.77
• Current Ratio: 0.89
• Quick Ratio: 0.59

Sales & Book Value

• Annual Sales: £1.78 million
• Price / Sales: 0.81
• Cash Flow: GBX 0.01 per share
• Price / Cash Flow: 9.00
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,900,000,000
• Free Float: N/A
• Market Cap: £1.44 million
• Optionable: Not Optionable
• Beta: 0.78